TRACON Pharmaceuticals Announces FDA Approval of Amended ENVASARC Protocol
Go back to TRACON Pharmaceuticals Announces FDA Approval of Amended ENVASARC Protocol| (NASDAQ: TCON) | Delayed: 1.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.43 | 52 Week High | $12.49 | |||
| Open | $1.43 | 52 Week Low | $4.00 | |||
| Day High | $1.43 | P/E | N/A | |||
| Day Low | $1.43 | EPS | $0.00 | |||
| Volume | 100 | |||||
